Recurrent Solid Tumors: Clinical Trials

2 trials for Recurrent Solid Tumors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Terminated 1

Follow Recurrent Solid Tumors: new trials by email Literature Review of Recurrent Solid Tumors trials Research Report on Recurrent Solid Tumors

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Master Protocol for Basket Clinical Trials of Targeted Therapies Based on Proteome and Whole Exome Sequencing Screening in Patients With Advanced Solid Tumors
Homologous Recombination Deficiency (HRD), ALK/ROS1/MET, standard care treatment - Advanced Solid Tumors, Metastatic Solid Tumors
Not applicableActive not recruitingNational Cancer Center, Korea28002024-11-182026-10-23
Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors
Peripheral Blood Stem Cell Transplant - High Risk Solid Tumors, Recurrent Solid Tumors
Not applicableTerminatedEmory University32003-05-012013-12-11

Narrower conditions

Kenny-Caffey syndrome, Type 1 (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Peripheral Blood Stem Cell Transplantation (1)

Sponsors

Emory University (1)  ·  National Cancer Center, Korea (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Kuang-Yueh Chiang, MD (1)  ·  Young-Woo Kim (1)

Results publications

PMID 25043054, PMID 27251275, PMID 27372738, PMID 35939768, PMID 38917788